ATAGI statement on meningococcal ACWY vaccine (Nimenrix®) for adolescents

Downloads

ATAGI statement on meningococcal ACWY vaccine (Nimenrix®) for adolescents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
5 April 2019
Publication type: 
Standard
Intended audience: 
Health professionals
Description: 

The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP).

It includes information about:

  • recommendations for the use of meningococcal ACWY vaccine
  • safety and effectiveness of the meningococcal ACWY vaccine
  • eligibility for NIP funded meningococcal ACWY vaccine
  • contraindications for the meningococcal ACWY vaccine
  • meningococcal vaccines available for use in Australia.